These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 36551364

  • 1. Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study.
    Sirijatuphat R, Thawornkaew S, Ruangkriengsin D, Thamlikitkul V.
    Antibiotics (Basel); 2022 Nov 26; 11(12):. PubMed ID: 36551364
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia.
    Shi H, Lee JS, Park SY, Ko Y, Eom JS.
    Infect Drug Resist; 2019 Nov 26; 12():3925-3934. PubMed ID: 31920347
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis.
    Huang C, Chen I, Tang T.
    J Clin Med; 2022 Jun 06; 11(11):. PubMed ID: 35683622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods.
    Rodjun V, Houngsaitong J, Montakantikul P, Paiboonvong T, Khuntayaporn P, Yanyongchaikit P, Sriyant P.
    Antibiotics (Basel); 2020 Aug 14; 9(8):. PubMed ID: 32823820
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
    Huang YS, Wang JT, Sheng WH, Chuang YC, Chang SC.
    J Microbiol Immunol Infect; 2015 Oct 14; 48(5):545-51. PubMed ID: 24662017
    [Abstract] [Full Text] [Related]

  • 15. Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials.
    Cheng IL, Chen YH, Lai CC, Tang HJ.
    J Clin Med; 2018 Aug 10; 7(8):. PubMed ID: 30103414
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
    Cheng A, Chuang YC, Sun HY, Sheng WH, Yang CJ, Liao CH, Hsueh PR, Yang JL, Shen NJ, Wang JT, Hung CC, Chen YC, Chang SC.
    Crit Care Med; 2015 Jun 10; 43(6):1194-204. PubMed ID: 25793437
    [Abstract] [Full Text] [Related]

  • 18. Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis.
    Katip W, Oberdorfer P.
    Pharmaceutics; 2021 Jan 26; 13(2):. PubMed ID: 33530483
    [Abstract] [Full Text] [Related]

  • 19. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I, Zer Y, Bosnak VK, Mete AO, Namiduru M.
    J Int Med Res; 2013 Dec 26; 41(6):1830-7. PubMed ID: 24265334
    [Abstract] [Full Text] [Related]

  • 20. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P, Moretti C, Vullo V, Visca P, Venditti M.
    BMC Infect Dis; 2015 Sep 30; 15():393. PubMed ID: 26424078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.